Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Nov 1;166(5):1300–1309. doi: 10.1084/jem.166.5.1300

Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts

PMCID: PMC2189663  PMID: 2824651

Abstract

The human beta 2 interferon (IFN-beta 2) gene, a gene that also codes for B cell differentiation factor 2 (BSF-2), plasmacytoma/hybridoma growth factor (HGF), and hepatocyte-stimulating factor (HSF), is expressed in a variety of lymphoid and nonlymphoid tissues. Endotoxin, or bacterial lipopolysaccharide (LPS) preparations derived from the outer membrane of Escherichia coli or Salmonella typhimurium rapidly elevate IFN-beta 2 mRNA level in human skin fibroblasts (FS-4 strain). E. coli-derived LPS enhances IFN-beta 2 mRNA expression in FS-4 fibroblasts at a concentration as low as 0.3 ng/ml; this response is near-maximal in the range of 0.1-1 microgram/ml LPS. The increase in IFN-beta 2 mRNA level caused by LPS in FS-4 cells is detected within 30 min after addition of LPS, is sustained for at least 20 h thereafter, appears to involve the protein kinase C signal transduction pathway, does not require new protein synthesis, and is inhibited by dexamethasone in a dose-dependent fashion (in the range 10(-6)-10(-8) M). Cultures of LPS-treated FS-4 cells exhibit an antiviral state against vesicular stomatitis virus, which can be prevented by anti-IFN- beta antiserum. Medium obtained from LPS-treated FS-4 cell cultures enhances the number of immunoglobulin-secreting cells in cultures of human B-lymphoblastoid (CESS) cells. Thus, LPS may trigger a number of host defense mechanisms in the course of infection due to Gram-negative bacteria by enhancing IFN-beta 2 production by the ubiquitous fibroblast.

Full Text

The Full Text of this article is available as a PDF (724.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON H. C., McCARTY M. Determination of C-reactive protein in the blood as a measure of the activity of the disease process in acute rheumatic fever. Am J Med. 1950 Apr;8(4):445–455. doi: 10.1016/0002-9343(50)90226-9. [DOI] [PubMed] [Google Scholar]
  2. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986 Apr 17;320(6063):584–588. doi: 10.1038/320584a0. [DOI] [PubMed] [Google Scholar]
  3. Buckingham R. B., Castor C. W. Rheumatoid behavior in normal human synovial fibroblasts induced by extracts of Gram-negative bacteria. J Lab Clin Med. 1975 Mar;85(3):422–435. [PubMed] [Google Scholar]
  4. CARVER D. H., NAFICY K. Inhibition of arbor viruses (group A) by a protein-like constituent of a corynebacterium. Proc Soc Exp Biol Med. 1962 Nov;111:356–360. doi: 10.3181/00379727-111-27791. [DOI] [PubMed] [Google Scholar]
  5. CARVER D. H., NAFICY K. STUDIES ON VIRAL INHIBITORS OF BIOLOGICAL ORIGIN. I. INHIBITION OF VIRAL REPLICATION BY PROTEIN-LIKE CONSTITUENTS OF BACTERIA. Proc Soc Exp Biol Med. 1964 Jun;116:548–552. doi: 10.3181/00379727-116-29303. [DOI] [PubMed] [Google Scholar]
  6. Darlington G. J., Wilson D. R., Lachman L. B. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol. 1986 Sep;103(3):787–793. doi: 10.1083/jcb.103.3.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dennis G. J., Mond J. J. Corticosteroid-induced suppression of murine B cell immune response antigens. J Immunol. 1986 Mar 1;136(5):1600–1604. [PubMed] [Google Scholar]
  8. GINSBERG H. S., GOEBEL W. F., HORSFALL F. L., Jr The inhibitory effect of polysaccharide on mumps virus multiplication. J Exp Med. 1948 May 1;87(5):385–410. doi: 10.1084/jem.87.5.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GINSBERG H. S., HORSFALL F. L., Jr Therapy of infection with pneumonia virus of mice (PVM); effect of a polysaccharide on the multiplication cycles of the virus and on the course of the viral pneumonia. J Exp Med. 1951 Feb;93(2):161–171. doi: 10.1084/jem.93.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gauldie J., Lamontagne L., Stadnyk A. Acute phase response in infectious disease. Surv Synth Pathol Res. 1985;4(2):126–151. doi: 10.1159/000156970. [DOI] [PubMed] [Google Scholar]
  11. Goldman N. D., Liu T. Y. Biosynthesis of human C-reactive protein in cultured hepatoma cells is induced by a monocyte factor(s) other than interleukin-1. J Biol Chem. 1987 Feb 15;262(5):2363–2368. [PubMed] [Google Scholar]
  12. Gresser I., Grogan E. A. Inhibition of arboviruses by a constituent of a staphylococcus. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1176–1181. doi: 10.3181/00379727-119-30407. [DOI] [PubMed] [Google Scholar]
  13. Gronowicz E., Coutinho A., Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976 Aug;6(8):588–590. doi: 10.1002/eji.1830060812. [DOI] [PubMed] [Google Scholar]
  14. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 1986 Sep 15;159(3):625–632. doi: 10.1111/j.1432-1033.1986.tb09931.x. [DOI] [PubMed] [Google Scholar]
  15. Horsfall F. L., McCarty M. THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM). J Exp Med. 1947 May 31;85(6):623–646. doi: 10.1084/jem.85.6.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kawamoto S., Hidaka H. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun. 1984 Nov 30;125(1):258–264. doi: 10.1016/s0006-291x(84)80362-9. [DOI] [PubMed] [Google Scholar]
  17. Kishimoto T. Factors affecting B-cell growth and differentiation. Annu Rev Immunol. 1985;3:133–157. doi: 10.1146/annurev.iy.03.040185.001025. [DOI] [PubMed] [Google Scholar]
  18. Kohase M., Henriksen-DeStefano D., May L. T., Vilcek J., Sehgal P. B. Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell. 1986 Jun 6;45(5):659–666. doi: 10.1016/0092-8674(86)90780-4. [DOI] [PubMed] [Google Scholar]
  19. Kohase M., Henriksen-Destefano D., Sehgal P. B., Vilcek J. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts. J Cell Physiol. 1987 Aug;132(2):271–278. doi: 10.1002/jcp.1041320211. [DOI] [PubMed] [Google Scholar]
  20. Kohase M., May L. T., Tamm I., Vilcek J., Sehgal P. B. A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol. 1987 Jan;7(1):273–280. doi: 10.1128/mcb.7.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koj A., Kurdowska A., Magielska-Zero D., Rokita H., Sipe J. D., Dayer J. M., Demczuk S., Gauldie J. Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes. Biochem Int. 1987 Mar;14(3):553–560. [PubMed] [Google Scholar]
  22. LIKAR M., BARTLEY E. O., WILSON D. C. Observations on the interaction of poliovirus and host cells in vitro. III. The effect of some bacterial metabolites and endotoxins. Br J Exp Pathol. 1959 Aug;40:391–397. [PMC free article] [PubMed] [Google Scholar]
  23. Macleod C. M., Avery O. T. THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : III. IMMUNOLOGICAL PROPERTIES OF THE C-REACTIVE PROTEIN AND ITS DIFFERENTIATION FROM NORMAL BLOOD PROTEINS. J Exp Med. 1941 Jan 31;73(2):191–200. doi: 10.1084/jem.73.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. May L. T., Helfgott D. C., Sehgal P. B. Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8957–8961. doi: 10.1073/pnas.83.23.8957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mizuguchi J., Beaven M. A., Li J. H., Paul W. E. Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4474–4478. doi: 10.1073/pnas.83.12.4474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaieda T., Yoshizaki K., Yamamura Y. T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol. 1981 Aug;127(2):412–416. [PubMed] [Google Scholar]
  27. Old L. J. Tumor necrosis factor (TNF). Science. 1985 Nov 8;230(4726):630–632. doi: 10.1126/science.2413547. [DOI] [PubMed] [Google Scholar]
  28. Pinero G. J., Kiatpongsah S., Hutchins M. O., Hoover J. The effect of endotoxin on the synthesis of connective tissue matrix components by pulp fibroblasts in vitro. J Endod. 1983 Jan;9(1):2–7. doi: 10.1016/S0099-2399(83)80004-1. [DOI] [PubMed] [Google Scholar]
  29. Revel M., Zilberstein A. Interferon-beta 2 living up to its name. Nature. 1987 Feb 12;325(6105):581–582. doi: 10.1038/325581b0. [DOI] [PubMed] [Google Scholar]
  30. Ritchie D. G., Fuller G. M. An in vitro bioassay for leukocytic endogenous mediator(s) using cultured rat hepatocytes. Inflammation. 1981 Dec;5(4):275–287. doi: 10.1007/BF00911093. [DOI] [PubMed] [Google Scholar]
  31. Ritchie D. G., Levy B. A., Adams M. A., Fuller G. M. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1530–1534. doi: 10.1073/pnas.79.5.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rosoff P. M., Cantley L. C. Lipopolysaccharide and phorbol esters induce differentiation but have opposite effects on phosphatidylinositol turnover and Ca2+ mobilization in 70Z/3 pre-B lymphocytes. J Biol Chem. 1985 Aug 5;260(16):9209–9215. [PubMed] [Google Scholar]
  33. Sehgal P. B., May L. T., Tamm I., Vilcek J. Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical. Science. 1987 Feb 13;235(4790):731–732. doi: 10.1126/science.3492764. [DOI] [PubMed] [Google Scholar]
  34. Sehgal P. B., Walther Z., Tamm I. Rapid enhancement of beta 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3663–3667. doi: 10.1073/pnas.84.11.3663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sehgal P. B., Zilberstein A., Ruggieri R. M., May L. T., Ferguson-Smith A., Slate D. L., Revel M., Ruddle F. H. Human chromosome 7 carries the beta 2 interferon gene. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5219–5222. doi: 10.1073/pnas.83.14.5219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Shimizu K., Hirano T., Ishibashi K., Nakano N., Taga T., Sugamura K., Yamamura Y., Kishimoto T. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II). J Immunol. 1985 Mar;134(3):1728–1733. [PubMed] [Google Scholar]
  37. Smith G. L. Synergistic action of bacterial lipopolysaccharides on serum-stimulated DNA synthesis in mouse embryo fibroblasts. Proc Soc Exp Biol Med. 1976 Oct;153(1):187–192. doi: 10.3181/00379727-153-39507. [DOI] [PubMed] [Google Scholar]
  38. Tillett W. S., Francis T. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS. J Exp Med. 1930 Sep 30;52(4):561–571. doi: 10.1084/jem.52.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Unanue E. R., Allen P. M. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987 May 1;236(4801):551–557. doi: 10.1126/science.2437650. [DOI] [PubMed] [Google Scholar]
  40. Vaheri A., Ruoslahti E., Sarvas M., Nurminen M. Mitogenic effect by lipopolysaccharide and pokeweed lectin on density-inhibited chick embryo fibroblasts. J Exp Med. 1973 Dec 1;138(6):1356–1364. doi: 10.1084/jem.138.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vilcek J., Freer J. H. Inhibition of Sindbis virus plaque formation by extracts of Escherichia coli. J Bacteriol. 1966 Dec;92(6):1716–1722. doi: 10.1128/jb.92.6.1716-1722.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Vilcek J., Ng M. H. Potentiation of the action of interferon by extracts of Escherichia coli. Virology. 1967 Mar;31(3):552–555. doi: 10.1016/0042-6822(67)90238-3. [DOI] [PubMed] [Google Scholar]
  43. Wightman P. D., Raetz C. R. The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J Biol Chem. 1984 Aug 25;259(16):10048–10052. [PubMed] [Google Scholar]
  44. Zilberstein A., Ruggieri R., Korn J. H., Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 1986 Oct;5(10):2529–2537. doi: 10.1002/j.1460-2075.1986.tb04531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES